Influenza A Virus Lacking M2 Protein as a Live Attenuated Vaccine
- 1 June 2009
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 83 (11) , 5947-5950
- https://doi.org/10.1128/jvi.00450-09
Abstract
Mutant influenza virus that lacks the transmembrane and cytoplasmic tail domains of M2 (M2 knockout [M2KO]) is attenuated in both cell culture and mice. Here, we examined the potency of M2KO influenza virus as a live attenuated influenza vaccine. M2KO virus grew as efficiently as the wild-type virus in cells stably expressing the wild-type M2, indicating the feasibility of efficient vaccine production. Mice intranasally vaccinated with M2KO virus developed protective immune responses and survived a lethal challenge with the wild-type virus, suggesting that the M2KO virus has potential as a live attenuated vaccine.Keywords
This publication has 38 references indexed in Scilit:
- Novel Approach to the Development of Effective H5N1 Influenza A Virus Vaccines: Use of M2 Cytoplasmic Tail MutantsJournal of Virology, 2008
- Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trialThe Lancet, 2006
- The Cytoplasmic Tail of the Influenza A Virus M2 Protein Plays a Role in Viral AssemblyJournal of Virology, 2006
- The Influenza A Virus M2Cytoplasmic Tail Is Required for Infectious Virus Production and Efficient Genome PackagingJournal of Virology, 2005
- Influenza A Virus Can Undergo Multiple Cycles of Replication without M2 Ion Channel ActivityJournal of Virology, 2001
- Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenzaThe Lancet, 2001
- Humoral and cell-mediated immunity to Vero cell-derived influenza vaccineVaccine, 2000
- InfluenzaThe Lancet, 1999
- Nuclear transport of influenza virus ribonucleoproteins: The viral matrix protein (M1) promotes export and inhibits importCell, 1991
- Evidence for host-cell selection of influenza virus antigenic variantsNature, 1983